SPET of the Abdomen

Part of the Developments in Nuclear Medicine book series (DNUM, volume 25)


Unlike studies of cerebral and myocardial perfusion the clinical role of SPET imaging of the abdomen has not been so immediately apparent. This has in part been due to the complex nature of the abdominal organs but, mainly because of the changing nature of the radiopharmaceuticals of clinical relevance to the abdomen. The main organs of interest are the liver and spleen, kidneys and adrenals, pancreas, gastrointestinal tract, great vessels and vertebrae. The introduction of rotating gamma cameras enabled the routine acquisition of tomographic data. However, during this period the introduction of high resolution X-ray CT, MRI and ultrasound has led to a demise in the demand for some of the more previously established radionuclide investigations such as liver scanning. Previously it has been common practice for much SPET imaging to be undertaken as an addition to planar imaging, rather than using it as the main imaging modality. In many instances, since gamma cameras could be easily used for acquiring tomographic data, SPET studies were merely tagged onto the end of planar imaging studies. This approach had little merit since the time the patient spent under the camera could be considerable if spot views, whole body scanning and tomographic imaging are all undertaken and in many studies little additional information to the spot views was obtained.


Hand Image Tomographic Data SPET Imaging Rotate Gamma Camera SPET Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Heertum RL, Brunetti JC and Yudd AP. Abdominal SPECT imaging Seminars Nucl Med (1987)XVII 230–246.Google Scholar
  2. 2.
    Krause T, Hanestein K, Studier-Fischer B, Schuemichen C, Moser E. Improved evaluation of Tc-99m red blood cell SPECT in hemangioma of the liver. J Nucl Med (1993) 34:375–380.PubMedGoogle Scholar
  3. 3.
    Ell PJ, Khan O, Jarritt PH and Cullum ID. Radionuclide section scanning: An atlas of clinical cases. (1992) Chapman and Hall London.Google Scholar
  4. 4.
    Kahn O and Ell PJ. Liver and Spleen. In: Computed emission tomography. Eds. PJ Ell and BL Holman. (1982) Oxford University Press.Google Scholar
  5. 5.
    Administration of Radioactive Substances Advisory Committee (1993) Notes for guidance on the administration of radioactive substances to persons for the purpose of diagnosis treatment and research. UK Dept. of Health. London.Google Scholar
  6. 6.
    Mut F, Glickman S, Maciano D et al. Optimum processing protocols for volume determination of the liver and spleen from SPECT imaging with Technetium-99m sulphur colloid. J Nucl Med (1988) 29:1768–1775.PubMedGoogle Scholar
  7. 7.
    Kavanagh GJ, Kavanagh JT, Kavanagh PBK, Irwin LE, Perkins AC and Swanson LA. Automated volume determination of the liver and spleen from Tc-99m colloid SPECT imaging: Quantification of the functioning and nonfunctioning tissue in disease. Clinical Nucl Med (1990) 15;495–500.CrossRefGoogle Scholar
  8. 8.
    Green AJ, Dewhurst SE, Begent RHJ, Bagshawe KD, Riggs SJ, Accurate quantification of I-131 distribution by gamma camera imaging. Eur J Nucl Med (1990) 16:361–365.9.PubMedCrossRefGoogle Scholar
  9. Flemming JS, Alaamer AA, Perring S. A technique for the absolute quantification of I-131 radiopharmaceuticals using SPECT. Nucl Med Comm (1993) 14:498–505.CrossRefGoogle Scholar
  10. 10.
    Mouratidis B, Asch JN, Gilday DL. Comparison of planar and SPECT Tc-99m-DMSA scintigraphy for the detection of renal cortical defects in children. Nucl Med Comm (1993) 14:82–86.CrossRefGoogle Scholar
  11. 11.
    Corbett R, Fullbrook A, Meller S et al. 123 Iodine metaiodobenzylguinadine single photon emission tomography in the assessment of children with neuroblastoma. Prog Clin Biol Res (1991) 366:479–485.PubMedGoogle Scholar
  12. 12.
    Munkner T. I-131-meta-iodobenzylguinadine scintigraphy of neuroblastoma. Sem Nucl Med (1985) 15:154–160.CrossRefGoogle Scholar
  13. 13.
    Krenning EP, Bakker WH, Breeman WAP, Koper JW, Kooij PPM, Ausema L, Lameris JS, Reubi JC and Lamberts SWJ. Localisation of endocrine related tumours with radioiodinated analogue of somatostatin. Lancet 1:242-244.Google Scholar
  14. 14.
    Westlin JE. Studies in nuclear medicine of the in vivo localisation and characterisation of neuroendocrine tumours. Acta Universitatis Upsaliensis, Comprehensive Summaries of Uppsala. Dissertations from the Faculty of Medicine, 382 (1992) University Sweden, Uppsala.Google Scholar
  15. 15.
    Perkins AC and Pimm MV. Immunoscintigraphy: Practical aspects and clinical applications. (1991). Wiley Liss. New York.Google Scholar
  16. 16.
    Perkin AC, Whalley DR, Ballantyne KC and Pimm MV. Gamma camera emission tomography using radiolabeled antibodies. Eur J Nucl Med 1985) 14:45–49.Google Scholar
  17. 17.
    Liehn JC, Loboguerrero A, Perault C, Demange L, Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence. Eur J Nucl Med (1992) 19:186–194. 18.PubMedCrossRefGoogle Scholar
  18. Badley AD, Camilleri M and O’Connor M. Noninvasive measurement of human ascending colon volume. Nucl Med Comm (1993) 14:485–489.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1995

Authors and Affiliations

There are no affiliations available

Personalised recommendations